Similar articles for PMID: 31937952

Year	Number of Results
1987	1
1989	1
1994	1
1996	1
1997	1
1998	3
1999	2
2000	2
2002	1
2003	2
2005	2
2006	3
2007	1
2008	2
2012	2
2013	2
2014	8
2015	11
2016	10
2017	6
2018	9
2019	9
2020	4
2022	1
2024	0

1

An immune-cell signature marks the brain in Alzheimer's disease.

Heneka MT. Heneka MT. Nature. 2020 Jan;577(7790):322-323. doi: 10.1038/d41586-019-03892-8. Nature. 2020. PMID: 31937952 No abstract available.

2

Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum.

Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, Botha H, Kantarci K, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr. Jones DT, et al. Cortex. 2017 Dec;97:143-159. doi: 10.1016/j.cortex.2017.09.018. Epub 2017 Oct 3. Cortex. 2017. PMID: 29102243 Free PMC article.

3

Alzheimer's pathology targets distinct memory networks in the ageing brain.

Maass A, Berron D, Harrison TM, Adams JN, La Joie R, Baker S, Mellinger T, Bell RK, Swinnerton K, Inglis B, Rabinovici GD, Düzel E, Jagust WJ. Maass A, et al. Brain. 2019 Aug 1;142(8):2492-2509. doi: 10.1093/brain/awz154. Brain. 2019. PMID: 31199481 Free PMC article.

4

Human herpesvirus 4 and adaptive immunity in Alzheimer's disease.

Kang JS, Liu PP. Kang JS, et al. Signal Transduct Target Ther. 2020 Apr 13;5(1):48. doi: 10.1038/s41392-020-0125-y. Signal Transduct Target Ther. 2020. PMID: 32296032 Free PMC article. No abstract available.

5

Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.

Oh H, Madison C, Baker S, Rabinovici G, Jagust W. Oh H, et al. Brain. 2016 Aug;139(Pt 8):2275-89. doi: 10.1093/brain/aww108. Epub 2016 May 13. Brain. 2016. PMID: 27190008 Free PMC article.

6

Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease.

Nakamura A, Cuesta P, Fernández A, Arahata Y, Iwata K, Kuratsubo I, Bundo M, Hattori H, Sakurai T, Fukuda K, Washimi Y, Endo H, Takeda A, Diers K, Bajo R, Maestú F, Ito K, Kato T. Nakamura A, et al. Brain. 2018 May 1;141(5):1470-1485. doi: 10.1093/brain/awy044. Brain. 2018. PMID: 29522156 Free PMC article.

7

Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.

Okada H, Ouchi Y, Ogawa M, Futatsubashi M, Saito Y, Yoshikawa E, Terada T, Oboshi Y, Tsukada H, Ueki T, Watanabe M, Yamashita T, Magata Y. Okada H, et al. Brain. 2013 Oct;136(Pt 10):3004-17. doi: 10.1093/brain/awt195. Epub 2013 Aug 24. Brain. 2013. PMID: 23975517

8

Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.

Dubois B, Epelbaum S, Nyasse F, Bakardjian H, Gagliardi G, Uspenskaya O, Houot M, Lista S, Cacciamani F, Potier MC, Bertrand A, Lamari F, Benali H, Mangin JF, Colliot O, Genthon R, Habert MO, Hampel H; INSIGHT-preAD study group. Dubois B, et al. Lancet Neurol. 2018 Apr;17(4):335-346. doi: 10.1016/S1474-4422(18)30029-2. Epub 2018 Feb 27. Lancet Neurol. 2018. PMID: 29500152

9

Vaccine-induced Aβ-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer's disease.

Rosset MB, Lui G, Dansokho C, Chaigneau T, Dorothée G. Rosset MB, et al. J Neuroinflammation. 2015 May 16;12:95. doi: 10.1186/s12974-015-0317-5. J Neuroinflammation. 2015. PMID: 25982697 Free PMC article.

10

Altered processing characteristics of beta-amyloid-containing peptides in cytosol and in media of familial Alzheimer's disease cells.

Matsumoto A. Matsumoto A. Biochim Biophys Acta. 1994 Feb 22;1225(3):304-10. doi: 10.1016/0925-4439(94)90011-6. Biochim Biophys Acta. 1994. PMID: 8312378

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

76 results

Results by year